Precipio Diagnostics, LLC
https://www.precipiodx.com/Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 17, 2026 | Precipio Announces Q2-2026 Financial Results | Precipio reported record quarterly revenue exceeding $7 million, driven by continued customer growth, higher product sales, and positive operating cash flow. Precipio delivered 22% year-over-year revenue growth in Q2 2026, ending the quarte... |
| Jun 15, 2026 | Precipio to Present at the Planet MicroCap Las Vegas | Precipio management will present at Planet MicroCap Las Vegas 2026, highlighting the company’s profitable growth strategy and specialty cancer diagnostics platform. CEO Ilan Danieli and COO Zaki Sabet will meet investors at Planet MicroCap ... |
| May 11, 2026 | B2i Digital Welcomes Precipio, Inc. as a New Featured Company | FY 2025 Revenue Grew 30% to $24.0 Million; Gross Margin Expanded to 45%; Achieved Cash Flow Positive in Q4-2025 The clinical lab doubles as a revenue-generating division, while also serving as a platform for the Product R&D team, enabli... |
| Sep 10, 2024 | GenomOncology Partners with Precipio to Advance Myeloid Testing and Reporting | CLEVELAND, Sept. 10, 2024 /PRNewswire/ -- September 4th, 2024. GenomOncology, a leading provider of precision medicine software, and Precipio, a specialty cancer diagnostics company, announced their strategic partnership aimed at advancing ... |
| May 6, 2024 | Precipio Secures a short-term $500K Credit Facility | |
| Nov 2, 2021 | Precipio Announces Q3-2021 Shareholder Update Call - Form 8-K | Precipio Announces Q3-2021 Shareholder Update Call Conference Call to be held on Monday, November 15th, 2021 at 5:00 PM EST NEW HAVEN, CT, (November 1st, 2021) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be ho... |
| Nov 1, 2021 | Precipio Announces Q3-2021 and year-end Shareholder Update Call | NEW HAVEN, Conn., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2021 update call on Monday, November 15th at 5:00 PM ET. The call will include updates on the com... |
| Aug 13, 2021 | Precipio : Announces Q2-2021 and year-end Shareholder Update Call | NEW HAVEN, Conn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET. The call will include updates on all of th... |
| Jul 29, 2021 | Precipio : Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M (Form 8-K) | Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M Increase of 65% YoY, and 29% from Q1-2021 due to strong Pathology Growth and HemeScreen NEW HAVEN, CT, (July 28, 2021) - Specialty diagnostics Company Precipio, Inc.(NASDAQ:... |
Reviews 0
FAQ about Precipio Diagnostics, LLC
How much funding has Precipio Diagnostics, LLC raised?
Precipio Diagnostics, LLC has raised $1.8M in total across 1 funding round.
What has the press written about Precipio Diagnostics, LLC?
Parsers VC has collected 14 articles mentioning Precipio Diagnostics, LLC, among them “Precipio Announces Q2-2026 Financial Results” (Aug 17, 2026) and “Precipio to Present at the Planet MicroCap Las Vegas” (Jun 15, 2026).
Is Precipio Diagnostics, LLC still active?
Precipio Diagnostics, LLC is probably closed: its latest activity on Parsers VC dates from Oct 29, 2026.